Mmu_circ_0001148 promotes endothlial-mesenchymal transition via regulating miR-218-5p/JMY axis and drives progression

Shang-Min Yu1, Jia-Qi Liu2, Lin-Lin Zhang3

  • 1Department of Pharmaceutics, School of Pharmacy, Bengbu Medical University, Bengbu 233000, Anhui, China.

Insights

A novel circular RNA, circ_0001148, promotes atherosclerosis by inducing endothelial-mesenchymal transition. It acts as a ceRNA, sponging miR-218-5p to regulate JMY, offering a potential therapeutic target for cardiovascular disease.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • RNA Biology

Background:

  • Atherosclerosis (AS) is a major cause of cardiovascular mortality.
  • Circular RNAs (circRNAs) are implicated in AS pathogenesis.
  • The role of circ_0001148 in AS requires elucidation.

Purpose of the Study:

  • Investigate the function of circ_0001148 in AS.
  • Elucidate the underlying molecular mechanism of circ_0001148 in AS.
  • Explore circ_0001148 as a potential therapeutic target.

Main Methods:

  • Identification of aberrantly expressed circRNA in atherosclerotic tissues.
  • Functional analysis of circ_0001148's role in endothelial-mesenchymal transition (EndMT).
  • Mechanism analysis involving competitive endogenous RNA (ceRNA) interactions (circ_0001148/miR-218-5p/JMY axis).

Main Results:

  • circ_0001148 promotes EndMT and accelerates atherosclerotic plaque formation.
  • circ_0001148 functions as a ceRNA, sponging miR-218-5p to regulate JMY expression.
  • Overexpression of circ_0001148-induced AS progression was attenuated by miR-218-5p mimics or JMY deficiency.

Conclusions:

  • A novel signaling network: circ_0001148 promotes atherogenesis via the miR-218-5p/JMY axis.
  • circ_0001148 plays a significant role in AS development.
  • This pathway presents a potential therapeutic strategy for atherosclerosis.